Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.3274
Delayed Data
As of Apr 29
 +0.0024 / +0.74%
Today’s Change
0.20
Today|||52-Week Range
0.44
-19.95%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$225.9M

Company Description

Elite Pharmaceuticals, Inc. is a pharmaceutical company, which specializes in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology, as it relates to abuse resistant products. Its strategy includes off-patent drug products for life cycle management and developing generic versions of controlled-release drug products. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.

Contact Information

Elite Pharmaceuticals, Inc.
165 Ludlow Avenue
Northvale New Jersey 07647
P:(201) 750-2646
Investor Relations:
(518) 398-6222

Employees

Shareholders

Individual stakeholders26.18%
Mutual fund holders0.16%
Other institutional0.01%

Top Executives

Nasrat A. HakimChairman, President & Chief Executive Officer
Doug PlasscheExecutive Vice President-Operations
Carter J. WardChief Financial Officer, Secretary & Treasurer
Jason LepreeVice President-Scientific Affairs
Christopher C. DickHead-Development